Ireland· IE-PA-EU/1/00/165/008
Ovitrelle 250 micrograms solution for injection in pre-filled pen
A choriogonadotropin alfa product containing choriogonadotropin alfa, registered in Ireland by Merck Europe B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Choriogonadotropin alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC G03GA08 (choriogonadotropin alfa), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 9 of them publish a price we can compare per daily dose
Choriogonadotropin alfa · ATC G03GA08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Choriogonadotropin alfa
- Manufacturer
- Merck Europe B.V.
- Country
- Ireland (IE)
- ATC code
- G03GA08
- ATC class
- Choriogonadotropin alfa
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/00/165/008
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Choriogonadotropin alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsOvitrelle 250 microgram oplossing voor injectie in voorgevulde penMerck Europe B.V.
- FinlandOvitrelleMerck Europe B.V.
- NorwayOvitrelleMerck
- United KingdomOvitrelle 250microgram powder and solvent for solution for injection vialsMerck Serono Ltd
- CanadaOVIDRELEMD SERONO, A DIVISION OF EMD INC., CANADA
- CzechiaOVITRELLEMerck Europe B.V., Amsterdam
- FranceOVITRELLE 250 microgrammes, solution injectable en stylo prérempliMERCK EUROPE (PAYS-BAS)
- IcelandOvitrelleMerck Europe B.V.*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ovitrelle
- Liechtenstein · Ovitrelle
- Norway · Ovitrelle
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/093ca77a-0bb3-4f78-924b-0d35fe151055 GET /v1/drugs/093ca77a-0bb3-4f78-924b-0d35fe151055?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"G03GA",
"G03GA08"
],
"strength": null,
"pa_number": "EU/1/00/165/008",
"substances": [
"Choriogonadotropin alfa"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "23/06/2011",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about choriogonadotropin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.